AbbVie
ABBV
#26
Rank
ยฃ260.38 B
Marketcap
ยฃ147.42
Share price
-0.08%
Change (1 day)
18.06%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total debt

Total debt on the balance sheet as of June 2024 : ยฃ53.82 B

According to AbbVie's latest financial reports the company's total debt is ยฃ53.82 B. A companyโ€™s total debt is the sum of all current and non-current debts.

AbbVie - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2023-12-31ยฃ46.61 B-10.87%
2022-12-31ยฃ52.29 B-7.7%
2021-12-31ยฃ56.66 B-10.11%
2020-12-31ยฃ63.03 B25.36%
2019-12-31ยฃ50.28 B59.16%
2018-12-31ยฃ31.59 B14.26%
2017-12-31ยฃ27.64 B-7.4%
2016-12-31ยฃ29.85 B39.85%
2015-12-31ยฃ21.34 B121.91%
2014-12-31ยฃ9.62 B7.92%
2013-12-31ยฃ8.91 B-8.02%
2012-12-31ยฃ9.69 B31282.83%
2011-12-31ยฃ30.88 M

Total debt for similar companies or competitors

Company Total debt differencediff. Country
ยฃ52.32 B-2.77%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ41.14 B-23.54%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ22.01 B-59.10%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ47.73 B-11.31%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ17.79 B-66.94%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ5.07 B-90.57%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ16.33 B-69.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ25.55 B-52.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ0.19 B-99.64%๐Ÿ‡บ๐Ÿ‡ธ USA